Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Stem cell factor restores hepatocyte proliferation in IL-6 knockout mice following 70% hepatectomy
Xiaodan Ren, … , Audra Carpenter, Lisa Colletti
Xiaodan Ren, … , Audra Carpenter, Lisa Colletti
Published November 1, 2003
Citation Information: J Clin Invest. 2003;112(9):1407-1418. https://doi.org/10.1172/JCI17391.
View: Text | PDF
Article Hepatology

Stem cell factor restores hepatocyte proliferation in IL-6 knockout mice following 70% hepatectomy

  • Text
  • PDF
Abstract

Stem cell factor (SCF) is a molecule with known proliferative effects on hematopoietic cells. More recent studies suggest that this molecule may also have effects on cellular differentiation and proliferation in other types of cells. The current investigations demonstrate that there is a large reservoir of SCF in the liver, that hepatic SCF levels change dramatically following partial hepatectomy in mice, and that SCF blockade, either by administration of anti-SCF antibodies or by using genetically altered, SCF-deficient mice, inhibits hepatocyte proliferation after partial hepatectomy; if SCF is replaced in the genetically SCF-deficient mice after partial hepatectomy, hepatocyte proliferation is restored to that seen in WT animals. Furthermore, SCF administration to IL-6 knockout mice also restores hepatocyte proliferation to normal. In vitro studies using primary mouse hepatocytes demonstrate that SCF causes hepatocyte proliferation and is induced by IL-6 and that treatment with anti-SCF antibodies inhibits IL-6–induced hepatocyte proliferation. Further in vivo studies in IL-6 knockout mice demonstrate that SCF administration to these animals increases p-stat3 levels, suggesting that the SCF-induced increase in hepatocyte proliferation in this system is stat3-mediated.

Authors

Xiaodan Ren, Cory Hogaboam, Audra Carpenter, Lisa Colletti

×

Figure 7

Options: View larger image (or click on image) Download as PowerPoint
BrdU staining following partial hepatectomy in Sl/Sld or WT mice treated...
BrdU staining following partial hepatectomy in Sl/Sld or WT mice treated with IL-6 or vehicle. Sl/Sld or WT mice were subjected to 70% hepatectomy with and without treatment with exogenous IL-6. Four treatment groups were studied: WT + vehicle, WT + IL-6, Sl/Sld + vehicle, and Sl/Sld + IL-6. Administration of IL-6 to WT animals had minimal effects, as did IL-6 administration to Sl/Sld mice. (*P < 0.05 for Sl/Sld + vehicle and Sl/Sld + IL-6 vs. WT + vehicle and WT + IL-6; **P < 0.05 for Sl/Sld + IL-6 vs. all other groups).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts